Deerfield Management’s Abeona Therapeutics ABEO Stock Holding History

Deerfield Management’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40,000	Closed	-$211K	–	84
2025 Q4	$211K	Buy	+40,000	New	+$201K	﹤0.01%	143
2023 Q3	–	Sell	-869,565	Closed	-$3.5M	–	89
2023 Q2	$3.5M	Hold	869,565	–	–	0.07%	81
2023 Q1	$2.45M	Hold	869,565	–	–	0.05%	85
2022 Q4	$2.68M	Buy	+869,565	New	+$3.25M	0.06%	81
2015 Q2	–	Sell	-13,996	Closed	-$1.1M	–	122
2015 Q1	$1.1M	Sell	13,996 -899	-6%	-$72.4K	0.04%	108
2014 Q4	$1.28M	Buy	+14,895	New	+$1.34M	0.05%	102

Other funds holding ABEO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deerfield Management's ABEO Position: Q1 2026 in Review

Deerfield Management sold out of Abeona Therapeutics (ABEO) in Q1 2026, closing a stake of 40,000 shares — an estimated $211K sold.

Deerfield Management first reported a position in ABEO in Q4 2014 and held it in 6 quarters. The position peaked at $3.5M in Q2 2023. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

Deerfield Management reported no remaining Abeona Therapeutics position as of Q1 2026 after selling out during the quarter.
Deerfield Management sold 40,000 Abeona Therapeutics shares in Q1 2026, an estimated $211K.
Deerfield Management first reported a position in Abeona Therapeutics in Q4 2014 and held it in 6 quarters.
Deerfield Management's Abeona Therapeutics position peaked at $3.5M in Q2 2023.
108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Deerfield Management's 13F filing for Q1 2026, filed 15 May 2026.